Mycotoxins and Human Diseases
A special issue of Toxins (ISSN 2072-6651).
Deadline for manuscript submissions: closed (31 August 2013) | Viewed by 87630
Special Issue Editor
Special Issue Information
Dear Colleagues,
Mycotoxins are produced as a consequence of fungal metabolism. While the fungi represent a very large population of organisms, most important mycotoxins are produced by a subpopulation of fungi commonly known as molds. Mycotoxins are secondary metabolites in that the organisms that produce them do not need to produce them to survive. Indeed, it is not known why molds produce mycotoxins, but we do know that the production of mycotoxins has important consequences for man and his animals. The ingestion of certain mycotoxins (e.g., aflatoxins) can be an important cause of liver cancer in humans. Also, the ingestion of certain mycotoxins (e.g., trichothecene mycotoxins like the satratoxins of Stachybotrys chartarum) can be important causes of poisonings in horses when they ingest hay on which the above mentioned organism has grown. In addition, the trichothecene mycotoxins of Stachybotrys chartarum have recently been shown to be in the air of water damaged buildings (WDB) infested with this organism, where they can be inhaled. These toxins have actually been shown to be in the bodies of people inhabiting these buildings. These trichothecene mycotoxins are highly toxic, having been designated as “biological warfare weapons” by no less an authority than the Office of the Surgeon General and the United States Army. Therefore, it is no surprise that the presence of these toxins in the indoor environment is considered to be highly problematic. The consequences of exposure to these mycotoxins in WDB are a topic of great debate in the phenomenon known as “Sick Building Syndrome”. In this special issue devoted to mycotoxins, hopefully some of the questions regarding these important toxins will be answered.
Prof. Dr. David C. Straus
Guest Editor
Submission
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed Open Access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs).
Keywords
- mycotoxins
- molds
- aflatoxins
- satratoxins
- Stachybotrys chartarum
- water damaged buildings
- sick building syndrome
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
